TEVA Trading Analysis - 09/16/2026 04:52 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for TEVA include:

• Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a new generic version of a popular medication, expanding its portfolio of affordable treatment options.
• The company received FDA approval for a new indication of one of its key products, broadening its market reach.
• TEVA reported a significant increase in sales for its flagship medication, attributing the growth to strong market demand and effective marketing strategies.

These headlines suggest a positive outlook for TEVA, with the company expanding its product offerings, receiving regulatory approvals, and experiencing sales growth. This context supports a bullish technical and sentiment analysis.

Fundamental Analysis:

Based on the provided fundamentals data:

• Total Revenue: $14,104,000,000
• Trailing EPS: $0.60
• Trailing P/E: 65.42
• Price-to-Book: 11.77
• Debt-to-Equity: 4.14
• Return on Equity (ROE): 9.14%
• Gross Margins: 64.41%
• Operating Margins: 11.36%
• Profit Margins: 5.03%

The fundamentals indicate:

• TEVA has a high P/E ratio of 65.42, suggesting potential overvaluation.
• The debt-to-equity ratio is high at 4.14, which could be a concern.
• ROE is positive at 9.14%, indicating effective use of shareholder capital.
• Margins are generally healthy, with gross margins at 64.41% and operating margins at 11.36%.

Overall, while TEVA shows some fundamental strengths, the high P/E and debt-to-equity ratios present concerns.

Current Market Position:

Current price: $38.53

Recent price action: The stock has shown an uptrend, with the current price near the upper end of its recent range.

Intraday momentum: The minute bars indicate a slight uptick in the last few minutes of trading.

Technical Analysis:

The technical indicators suggest:

• RSI is neutral at 53.37.
• MACD is bullish, indicating upward momentum.
• The stock is above its 20-day SMA ($37.24) and 50-day SMA ($35.12), indicating a positive trend.

Bollinger Bands: The stock price is near the upper band, which could indicate overbought conditions or strong upward momentum.

30-day high/low context: The current price is near the upper end of its 30-day range, suggesting strength.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume analysis:

• Call dollar volume: $4,247,860
• Put dollar volume: $98,993
• Call percentage: 97.7%

The pure directional positioning suggests near-term expectations are bullish, with a significant majority of call buying.

Key Price Levels:

25-Day Price Forecast:

TEVA is projected for $39.50 to $41.20

Rationale:

• Based on current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).
• Support/resistance levels may act as barriers or targets.

Defined Risk Strategy Recommendations:

Based on the price forecast of $39.50 to $41.20:

• Recommended strategy: Bull Call Spread
• Strategy details:
• Buy 261009C00038000 (TEVA261009C00038000) at $2.26
• Sell 261009C00041000 (TEVA261009C00041000) at $0.01
• Net debit: $2.25
• Max profit: $0.75
• Max loss: $2.25
• Breakeven: $40.25
• ROI%: 33.3%

Risk Factors:

• Technical warning signs or weaknesses: Overbought conditions near the upper Bollinger Band.
• Sentiment divergences from price action: None apparent.
• Volatility and ATR considerations: ATR is at 1.22, indicating moderate volatility.
• What could invalidate the thesis: Unexpected negative news or a significant market downturn.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: TEVA shows bullish momentum with strong institutional buying and technical indicators supporting continuation higher.